{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:01:37Z","timestamp":1779962497379,"version":"3.53.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-01099"],"award-info":[{"award-number":["2022-01099"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","award":["1573\/24"],"award-info":[{"award-number":["1573\/24"]}],"id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grants from the Swedish state under the agreement between the Swedish government and the county councils","award":["the ALF-agreement (FoUI-1000568)"],"award-info":[{"award-number":["the ALF-agreement (FoUI-1000568)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To investigate whether antidiabetic drugs have a biological basis to be repurposed in PD prevention, we applied a drug target Mendelian randomization framework to assess associations between genetic variation in antidiabetic drug targets and PD risk or age at onset (AAO). Instrumental variables (IVs) were derived from GWAS summary statistics on fasting glucose (FG), glycated hemoglobin (HbA1c), and gene expression data from GTEx. Apart from SGLT2 inhibitors, all other antidiabetic drugs of interest could be instrumented through our methods. Positive and negative control analyses were carried out to validate 20 IVs in the FG arm and 23 IVs in the HbA1c arm. DPP-4 inhibitors failed the positive control. GWAS summary statistics for PD risk and AAO data were sourced from the IPDGC and COURAGE-PD consortia, resulting in 42 083 cases\/457 090 controls for risk and 37 103 PD cases for AAO. MR analyses showed no significant associations across consortia or in meta-analysis. These findings do not support a causal role of genetic variation in antidiabetic drug targets in PD risk or AAO.<\/jats:p>","DOI":"10.1038\/s41531-026-01398-5","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:55:28Z","timestamp":1779951328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic variation in antidiabetic drug targets: associations with Parkinson\u2019s disease risk and age at onset"],"prefix":"10.1038","volume":"12","author":[{"given":"Katalin","family":"Vincze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Szwajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9","family":"Domenighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Sugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Ashok Kumar Sreelatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj Reddy","family":"Bobbili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Radivojkov-Blagojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lichtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena G.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Edsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Mellick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Pirker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Rogaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulev","family":"Koks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pille","family":"Taba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lesage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Chartier-Harlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Mutez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela B.","family":"Deutschlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena F.","family":"Burbulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges M.","family":"Hadjigeorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimos","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina Maria","family":"Simitsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza Maria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Straniero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zecchinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Annesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Kolber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart PC","family":"Van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Pihlstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Correia Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Bardien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ezquerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Puschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Krainc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt J.","family":"Farrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zied","family":"Landoulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejko","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"H\u00e4gg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wirdefeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson\u2019s Disease (COURAGE-PD) Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9","family":"Domenighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Sugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Ashok Kumar Sreelatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj Reddy","family":"Bobbili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Radivojkov-Blagojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lichtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena G.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Edsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Mellick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Pirker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Rogaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulev","family":"Koks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pille","family":"Taba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lesage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Chartier-Harlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Mutez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela B.","family":"Deutschlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena F.","family":"Burbulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges M.","family":"Hadjigeorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimos","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina Maria","family":"Simitsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza Maria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Straniero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zecchinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Annesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Kolber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart PC","family":"Van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Pihlstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Correia Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Bardien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ezquerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Puschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Krainc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt J.","family":"Farrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zied","family":"Landoulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejko","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wirdefeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"1398_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz, J. D. et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 344\u2013381 (2024).","journal-title":"Lancet Neurol."},{"key":"1398_CR2","doi-asserted-by":"crossref","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet pp. 2284\u20132303, https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014067362100218X (2021).","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"1398_CR3","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/genes16121482","volume":"16","author":"E Kafantari","year":"2025","unstructured":"Kafantari, E., Atterling Brolin, K., Wallenius, J., Swanberg, M. & Puschmann, A. WES-based screening of a Swedish patient series with Parkinson\u2019s disease. Genes 16, 1482 (2025).","journal-title":"Genes"},{"issue":"12","key":"1398_CR4","doi-asserted-by":"publisher","first-page":"e83940","DOI":"10.1371\/journal.pone.0083940","volume":"8","author":"JA Santiago","year":"2013","unstructured":"Santiago, J. A. & Potashkin, J. A. Integrative network analysis unveils convergent molecular pathways in Parkinson\u2019s disease and diabetes. PLoS One 8(12), e83940 (2013).","journal-title":"PLoS One"},{"key":"1398_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2011.138","volume":"8","author":"J Szendroedi","year":"2011","unstructured":"Szendroedi, J., Phielix, E. & Roden, M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8, 92\u2013103 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1398_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong, J. L. Y., de Pablo-Fernandez, E., Foltynie, T. & Noyce, A. J. The association between Type 2 Diabetes Mellitus and Parkinson\u2019s disease. J. Parkinsons Dis. 10, 775\u2013789 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1398_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145\u2013146","author":"D Athauda","year":"2016","unstructured":"Athauda, D. & Foltynie, T. Insulin resistance and Parkinson\u2019s disease: a new target for disease modification?. Prog. Neurobiol. 145\u2013146, 98\u2013120 (2016).","journal-title":"Prog. Neurobiol."},{"key":"1398_CR8","volume":"11","author":"Y Aguirre-Vidal","year":"2024","unstructured":"Aguirre-Vidal, Y., Montes, S., Mota-L\u00f3pez, A. C. & Navarrete-V\u00e1zquez, G. Antidiabetic drugs in Parkinson\u2019s disease. Clin. Park Relat. Disord. 11, 100265 (2024).","journal-title":"Clin. Park Relat. Disord."},{"key":"1398_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1398_CR10","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.csbj.2022.05.057","volume":"20","author":"S Zhu","year":"2022","unstructured":"Zhu, S., Bai, Q., Li, L. & Xu, T. Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents. Comput Struct. Biotechnol. J. 20, 2839 (2022).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"1398_CR11","doi-asserted-by":"publisher","first-page":"E650","DOI":"10.1212\/WNL.0000000000200771","volume":"99","author":"B Tang","year":"2022","unstructured":"Tang, B. et al. Genetic variation in targets of antidiabetic drugs and alzheimer disease risk: a Mendelian randomization study. Neurology 99, E650\u2013E659 (2022).","journal-title":"Neurology"},{"key":"1398_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176117","volume":"961","author":"SV Birajdar","year":"2023","unstructured":"Birajdar, S. V., Mazahir, F., Alam, M. I., Kumar, A. & Yadav, A. K. Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders. Eur. J. Pharm. 961, 176117 (2023).","journal-title":"Eur. J. Pharm."},{"key":"1398_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14821","volume":"39","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Metformin and the risk of neurodegenerative diseases in patients with diabetes: a meta-analysis of population-based cohort studies. Diabet. Med. 39, e14821 (2022).","journal-title":"Diabet. Med."},{"key":"1398_CR14","doi-asserted-by":"publisher","unstructured":"Shi, Q., Liu, S., Fonseca, V. A., Thethi, T. K. & Shi, L. Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus. BMJ Open 9 https:\/\/doi.org\/10.1136\/BMJOPEN-2018-024954 (2019).","DOI":"10.1136\/BMJOPEN-2018-024954"},{"key":"1398_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","volume":"18","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist, M. L. et al. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat. Disord. 18, 753\u2013758 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1398_CR16","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/brain\/awaa262","volume":"143","author":"R Brauer","year":"2020","unstructured":"Brauer, R. et al. Diabetes medications and risk of Parkinson\u2019s disease: a cohort study of patients with diabetes. Brain 143, 3067\u20133076 (2020).","journal-title":"Brain"},{"key":"1398_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/JPD-240272","volume":"14","author":"K McFarthing","year":"2024","unstructured":"McFarthing, K. et al. Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2024 update. J. Parkinsons Dis. 14, 899\u2013912 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1398_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/pds.5448","volume":"31","author":"K Sunnarborg","year":"2022","unstructured":"Sunnarborg, K. et al. Association between different diabetes medication classes and risk of Parkinson\u2019s disease in people with diabetes. Pharmacoepidemiol Drug Saf. 31, 875 (2022).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"1398_CR19","doi-asserted-by":"publisher","unstructured":"Lin, K. J. et al. Two birds one stone: the neuroprotective effect of antidiabetic agents on Parkinson disease\u2014focus on sodium-glucose cotransporter 2 (SGLT2) inhibitors. Antioxidants 10, https:\/\/doi.org\/10.3390\/ANTIOX10121935 (2021).","DOI":"10.3390\/ANTIOX10121935"},{"key":"1398_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/pcm.2023.5","volume":"1","author":"I Daghlas","year":"2023","unstructured":"Daghlas, I. & Gill, D. Mendelian randomization as a tool to inform drug development using human genetics. Camb. Prisms Precis. Med. 1, e16 (2023).","journal-title":"Camb. Prisms Precis. Med."},{"key":"1398_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00439-007-0448-6","volume":"123","author":"S Ebrahim","year":"2008","unstructured":"Ebrahim, S. & Davey Smith, G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?. Hum. Genet. 123, 15\u201333 (2008).","journal-title":"Hum. Genet."},{"key":"1398_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-26280-1","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm, C. S. et al. Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat. Commun. 12, 1\u201314 (2021).","journal-title":"Nat. Commun."},{"key":"1398_CR23","doi-asserted-by":"publisher","first-page":"26438","DOI":"10.1073\/pnas.2009838117","volume":"117","author":"DE Mor","year":"2020","unstructured":"Mor, D. E. et al. Metformin rescues Parkinson\u2019s disease phenotypes caused by hyperactive mitochondria. Proc. Natl. Acad. Sci. USA 117, 26438\u201326447 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1398_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111128","volume":"135","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Fei, L. & Duan, Y. Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study. Prog. Neuropsychopharmacol. Biol. Psychiatry 135, 111128 (2024).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1398_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3624","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu, J., Shi, X. & Shao, Y. Sodium-glucose cotransporter 1\/2 inhibition and risk of neurodegenerative disorders: a Mendelian randomization study. Brain Behav. 14, e3624 (2024).","journal-title":"Brain Behav."},{"key":"1398_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mds.29341","volume":"38","author":"NA Aziz","year":"2023","unstructured":"Aziz, N. A. & W\u00fcllner, U. Genetic variants in sulfonylurea targets affect Parkinson\u2019s disease risk: a two-sample Mendelian randomization study. Mov. Disord. 38, 703\u2013705 (2023).","journal-title":"Mov. Disord."},{"key":"1398_CR27","first-page":"1","volume":"14","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Identifying potential repurposable medications for Parkinson\u2019s disease through Mendelian randomization analysis. Sci. Rep. 14, 1\u201311 (2024).","journal-title":"Sci. Rep."},{"key":"1398_CR28","unstructured":"Domenighetti, C. et al. Association of Body Mass Index and Parkinson Disease A Bidirectional Mendelian Randomization Study. Neurology 10, 103 (2024)."},{"key":"1398_CR29","doi-asserted-by":"publisher","first-page":"E698","DOI":"10.1212\/WNL.0000000000200699","volume":"99","author":"S Grover","year":"2022","unstructured":"Grover, S. et al. Genome-wide association and meta-analysis of age at onset in Parkinson disease: evidence from the COURAGE-PD Consortium. Neurology 99, E698\u2013E710 (2022).","journal-title":"Neurology"},{"key":"1398_CR30","unstructured":"Landoulsi. Z. et al. Genome-wide association study of copy number variations in Parkinson\u2019s disease. medRxiv https:\/\/www.medrxiv.org\/content\/10.1101\/2024.08.21.24311915v2.full-text (2025)."},{"key":"1398_CR31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat, C. et al. Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms. Mov. Disord. 34, 866\u201375 (2019).","journal-title":"Mov. Disord."},{"key":"1398_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u2013102 (2019).","journal-title":"Lancet Neurol."},{"key":"1398_CR33","unstructured":"Magic Investigators - Data download. https:\/\/magicinvestigators.org\/downloads\/ (2025)."},{"key":"1398_CR34","unstructured":"UK Biobank - UK Biobank. https:\/\/www.ukbiobank.ac.uk\/ (2025)."},{"key":"1398_CR35","first-page":"1","volume":"10","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Genome-wide association study of medication-use and associated disease in the UK Biobank. Nat. Commun. 10, 1\u201310 (2019).","journal-title":"Nat. Commun."},{"key":"1398_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104803","volume":"96","author":"J Zheng","year":"2023","unstructured":"Zheng, J. et al. Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study. EBioMedicine 96, 104803 (2023).","journal-title":"EBioMedicine"},{"key":"1398_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Metformin: update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19, 460\u201376 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1398_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53209-7","volume":"14","author":"OI Gaal","year":"2024","unstructured":"Gaal, O. I. et al. GWAS-identified hyperuricemia-associated IGF1R variant rs6598541 has a limited role in urate mediated inflammation in human mononuclear cells. Sci. Rep. 14, 3565 (2024).","journal-title":"Sci. Rep."},{"key":"1398_CR39","unstructured":"GTEx Portal. https:\/\/www.gtexportal.org\/home\/downloads\/adult-gtex\/qtl (2025)."},{"key":"1398_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02223-0","volume":"18","author":"I Castilla-Cort\u00e1zar","year":"2020","unstructured":"Castilla-Cort\u00e1zar, I., Aguirre, G. A., Femat-Rold\u00e1n, G., Mart\u00edn-Estal, I. & Espinosa, L. Is insulin-like growth factor-1 involved in Parkinson\u2019s disease development? J. Transl. Med. 18, 1\u201317 (2020).","journal-title":"J. Transl. Med."},{"key":"1398_CR41","doi-asserted-by":"publisher","unstructured":"The Global Parkinson\u2019s Genetics Program (GP2) & Leonard, H. L. Novel Parkinson\u2019s disease genetic risk factors within and across European populations. medRxiv, https:\/\/doi.org\/10.1101\/2025.03.14.24319455 (2025).","DOI":"10.1101\/2025.03.14.24319455"},{"key":"1398_CR42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209805","volume":"103","author":"HK Kim","year":"2024","unstructured":"Kim, H. K. et al. SGLT2 inhibitor use and risk of dementia and Parkinson disease among patients with type 2 diabetes. Neurology 103, e209805 (2024).","journal-title":"Neurology"},{"key":"1398_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-022-00406-8","volume":"8","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Thiazolidinedione use and risk of Parkinson\u2019s disease in patients with type 2 diabetes mellitus. NPJ Parkinsons Dis. 8, 1\u20139 (2022). Dec 1.","journal-title":"NPJ Parkinsons Dis."},{"key":"1398_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jocn.2022.10.023","volume":"106","author":"L Chen","year":"2022","unstructured":"Chen, L., Tao, Y., Li, J. & Kang, M. Pioglitazone use is associated with reduced risk of Parkinson\u2019s disease in patients with diabetes: a systematic review and meta-analysis. J. Clin. Neurosci. 106, 154\u20138 (2022).","journal-title":"J. Clin. Neurosci."},{"key":"1398_CR45","doi-asserted-by":"publisher","first-page":"678649","DOI":"10.3389\/fneur.2021.678649","volume":"12","author":"X Qin","year":"2021","unstructured":"Qin, X. et al. Association between diabetes medications and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis. Front. Neurol. 12, 678649 (2021).","journal-title":"Front. Neurol."},{"key":"1398_CR46","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/mdc3.13893","volume":"10","author":"H Tang","year":"2023","unstructured":"Tang, H. et al. Meta-analysis of association between newer glucose-lowering drugs and risk of Parkinson\u2019s disease. Mov. Disord. Clin. Pr. 10, 1659\u201365 (2023).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1398_CR47","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","volume":"390","author":"D Athauda","year":"2017","unstructured":"Athauda, D. et al. Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet 390, 1664\u201375 (2017).","journal-title":"Lancet"},{"key":"1398_CR48","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","volume":"390","author":"WG Meissner","year":"2024","unstructured":"Meissner, W. G. et al. Trial of lixisenatide in early Parkinson\u2019s disease. N. Engl. J. Med. 390, 1176\u201385 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1398_CR49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","volume":"405","author":"N Vijiaratnam","year":"2025","unstructured":"Vijiaratnam, N. et al. Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson\u2019s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial. Lancet 405, 627\u201336 (2025).","journal-title":"Lancet"},{"key":"1398_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10654-024-01103-x","volume":"39","author":"G Zheng","year":"2024","unstructured":"Zheng, G., Chattopadhyay, S., Sundquist, J., Sundquist, K. & Ji, J. Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study. Eur. J. Epidemiol. 39, 535\u201348 (2024).","journal-title":"Eur. J. Epidemiol."},{"key":"1398_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2023","unstructured":"Burgess, S. et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 4, 186 (2023).","journal-title":"Wellcome Open Res."},{"key":"1398_CR52","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/ije\/dyz236","volume":"49","author":"D Gill","year":"2020","unstructured":"Gill, D., Walker, V. M., Martin, R. M., Davies, N. M. & Tzoulaki, I. Comparison with randomized controlled trials as a strategy for evaluating instruments in Mendelian randomization. Int J. Epidemiol. 49, 1404\u20136 (2020).","journal-title":"Int J. Epidemiol."},{"key":"1398_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt, A. F. et al. Genetic drug target validation using Mendelian randomisation. Nat. Commun. 11, 1\u201312 (2020).","journal-title":"Nat. Commun."},{"key":"1398_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/wellcomeopenres.16544.1","volume":"6","author":"D Gill","year":"2021","unstructured":"Gill, D. et al. Mendelian randomization for studying the effects of perturbing drug targets [version 1; peer review: awaiting peer review]. Wellcome Open Res 6, 1\u201311 (2021).","journal-title":"Wellcome Open Res"},{"key":"1398_CR55","unstructured":"PubChem. https:\/\/pubchem.ncbi.nlm.nih.gov\/ (2025)."},{"key":"1398_CR56","unstructured":"DGIdb. https:\/\/beta.dgidb.org\/ (2025)."},{"key":"1398_CR57","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. The trans-ancestral genomic architecture of glycemic traits. Nat. Genet. 53, 840\u201360 (2021).","journal-title":"Nat. Genet."},{"key":"1398_CR58","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet 45, 580\u20135 (2013).","journal-title":"Nat. Genet"},{"key":"1398_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.xhgg.2021.100083","volume":"3","author":"MH Quiver","year":"2021","unstructured":"Quiver, M. H. & Lachance, J. Adaptive eQTLs reveal the evolutionary impacts of pleiotropy and tissue-specificity while contributing to health and disease. Hum. Genet. Genomics Adv. 3, 100083 (2021).","journal-title":"Hum. Genet. Genomics Adv."},{"key":"1398_CR60","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u201318 (2023).","journal-title":"Nature"},{"key":"1398_CR61","unstructured":"Trait: Childhood asthma (age<16) - IEU OpenGWAS project. https:\/\/gwas.mrcieu.ac.uk\/datasets\/ukb-d-ASTHMA_CHILD\/ (2025)."},{"key":"1398_CR62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018). 2018.","journal-title":"eLife"},{"key":"1398_CR63","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2023)."},{"key":"1398_CR64","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck, S. et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439\u201340 (2005).","journal-title":"Bioinformatics"},{"key":"1398_CR65","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat. Protoc. 4, 1184\u201391 (2009).","journal-title":"Nat. Protoc."},{"key":"1398_CR66","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10, e1004383 (2014).","journal-title":"PLoS Genet"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01398-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01398-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01398-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:02:45Z","timestamp":1779958965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01398-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01398-5","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.Q. is currently working at Novo Nordisk, but the study was designed during her postdoctoral research at Karolinska Institutet. Novo Nordisk did not influence the submitted work. A.B.S. reports grants from Department of Defense, during the conduct of the study; grants from Michael J Fox Foundation, outside the submitted work. A.B.S. is an unpaid Scientific Advisory Board member for Cajal Neuroscience outside of the submitted work. A.B.S. is part of the Editorial board of Neurogenetics. A.B.S. was not involved in the journal\u2019s review of, or decisions related to, this manuscript.W.P. reports personal fees from Gr\u00fcnenthal, personal fees from AbbVie, personal fees from AOP Health Orphan, personal fees from Zambon, personal fees and other from Boehringer Ingelheim, personal fees from Stada, personal fees from Bial UCB Pharma, outside the submitted work. A.E.L. reports personal fees from AbbVie, personal fees from AFFiRis, personal fees from Janssen, personal fees from Biogen, personal fees from Merck, personal fees from Sun Pharma, personal fees from Corticobasal Solutions, personal fees from Sunovion, personal fees from Paladin, personal fees from Lilly, personal fees from Medtronic, personal fees from Theravance, personal fees from Lundbeck, personal fees from Retrophin, personal fees from Roche, personal fees from PhotoPharmics, outside the submitted work. P. T. was supported by the Grants PRG2736 and TEM-TA110 of the Estonian Research Council. A.B. reports grants from France Parkinson + FRC, grants from ANR - EPIG - Agence nationale de recherche, grants from ANR - JPND - Agence nationale de recherche, grants from RDS (Roger de Spoelberch Foundation), grants from France Alzheimer, grants from Institut de France, grants from ANR - EPIG, grants from FMR (maladies rares), outside the submitted work. A.B. is part of the editorial advisory board of Brain, as well as the Editorial board of Neurogenetics. A.B. was not involved in the journal\u2019s review of, or decisions related to, this manuscript. J.C.C. reports grants from the Michael J Fox Foundation, Sanofi, and served in advisory boards for Air Liquide, Biogen, Denali, Ever Pharma, Idorsia, Prevail Therapeutic, Theranexus, UCB, outside the submitted work. K.B. has received research funding from the Michael J. Fox Foundation for Parkinson\u2019s Research (MJFF-022343, MJFF-023275, MJFF-023365), the German Society for Parkinson DPG, the Health Forum Baden Wuerttemberg, the Else Kr\u00f6ner Fresenius Stiftung (ClinbrAIn), the University of Tuebingen, and from the German Research Foundation DFG (BR-655671-1. K.B. is a consultant for F. Hoffmann-La Roche Ltd., Vanqua Bio, and the Michael J. Fox Foundation for Parkinson\u2019s Research and has received speaker honoraria from Abbvie, Lundbeck, UCB and Zambon.\u2019 L.S. reports the following grants: PPMI2 (supported by the Michael J. Fox Foundation), IMPRIND-IMI2 Number 116060 (EU, H2020), \u201cTransferring autonomous and non-autonomous cell degeneration 3D models between EU and USA for development of effective therapies for neurodegenerative diseases (ND) - CROSS NEUROD\u201d (H2020-EU 1.3.3., Grant Number778003), \u00abChaperone-Mediated Autophagy in Neurodegeneration\u00bb (Hellenic Foundation for Research and Innovation Grant HFRI-FM17-3013), and \u201cCMA as a Means to Counteract alpha-Synuclein Pathology in Non-Human Primates\u201d Grant by the Michael J. Fox Foundation (Collaborator). L.S. is co-Head and PI at the NKUA of the General Secretariat of Research and Technology (GSRT)-funded Grant \u201cNational Network of Precision Medicine for Neurodegenerative Diseases\u201d. L.S. has served on an Advisory Board for Abbvie, ITF Hellas and Biogen and has received honoraria from Abbvie and Sanofi. There are no specific disclosures related to the current work. E.M.V. serves as Associate Editor of Journal of Medical Genetics, Section Editor of Pediatric Research, Member of the Editorial Board of Movement Disorders Clinical Practice; grants from the Italian Ministry of Health, CARIPLO Foundation, Pierfranco and Luisa Mariani Foundation, Telethon Foundation Italy, outside the submitted work. E.M.V. was not involved in the journal\u2019s review of, or decisions related to, this manuscript. N.H. reports grants from - Japan Agency for Medical Research and Development (AMED), grants from - Japan Society for the Promotion of Science (JSPS), grants from - Ministry of Education Culture,Sports,Science and Technology Japan; Grant-in-Aid for Scientific Research on Innovative Areas, personal fees and other from Dai-Nippon Sumitomo Pharma Co.,Ltd, personal fees and other from Takeda Pharmaceutical Co.,Ltd., personal fees and other from Kyowa Kirin Co.,Ltd., personal fees and other from GSK K.K, personal fees and other from Nippon Boehringer Ingelheim,Co.,Ltd, personal fees and other from FP Pharmaceutical Corporation, personal fees and other from Eisai Co.,Ltd., personal fees and other from Kissei Pharmaceutical Company, personal fees and other from Nihon Medi-physics Co.,Ltd, personal fees and other from Novartis Pharma K.K, personal fees and other from Biogen Idec Japan Ltd, personal fees and other from AbbVie, from Medtronic, Inc., other from Boston Scientific Japan, personal fees and other from Astellas Pharma Inc., grants and other from Ono Pharmaceutical Co.,Ltd, other from Nihon Pharmaceutical Co., Ltd, other from Asahi Kasei Medical Co.,Ltd, other from Mitsubishi Tanabe Pharma Corporation, personal fees and other from Daiichi Sankyo Co., other from OHARA Pharmaceutical Co.,Ltd, other from Meiji Seika Pharma, personal fees from Sanofi K.K., personal fees from Pfizer Japan Inc., personal fees from Alexion Pharmaceuticals, personal fees from Mylan N.V, personal fees from MSD K.K, personal fees from Lund Beck Japan, other from Hisamitsu Pharmaceutical Co.,Inc, outside the submitted work. K.N. reports grants from - Japan Society for the Promotion of Science (JSPS), outside the submitted work. P.K. reports other from Centre Hospitalier de Luxembourg; University of Luxembourg, grants from Fonds National de Recherche (FNR), from null, outside the submitted work. B.P.C.v.d.W. reports grants from ZonMw, Hersenstichting, Gossweiler Fund, Radboud university medical centre, and Christina Foundation outside the submitted work. B.P.C.v.d.W. has done paid consultancy for Biohaven Pharmaceuticals, Vico Therapeutics, and Servier, and receives roylaties from BSL\/Springer-Nature. B.R.B. reports grants from Netherlands Organization for Health Research and Development, grants from Michael J. Fox Foundation, grants from Parkinson Vereniging, grants from Parkinson Foundation, grants from Gatsby Foundation, grants from Verily Life Sciences, grants from Horizon 2020, grants from Topsector Life sciences and Health, grants from Stichting Parkinson Fonds, grants from UCB, grants from Abbvie, during the conduct of the study; personal fees from Biogen, personal fees from Abbvie, personal fees from Walk with Path, personal fees from UCB, personal fees from Abbvie, personal fees from Zambon, personal fees from Bial, personal fees from Roche, outside the submitted work; and Serves as editor-in-chief of the Journal of Parkinson\u2019s Disease and serves on the editorial board of Practical Neurology and Digital Biomarkers. B.R.B. was not involved in the journal\u2019s review of, or decisions related to, this manuscript. M.T. reports grants from Research Council of Norway, during the conduct of the study; grants from South-Eastern Norway Regional Health Authority, grants from Michael J. Fox Foundation, outside the submitted work. L.P. reports grants from Norwegian Health Association, grants from South-Eastern Norway Regional Health Authority, outside the submitted work. J.J.F. reports grants from GlaxoSmithKline, grants from Grunenthal, grants from Funda\u00e7\u00e3o MSD (Portugal), grants from TEVA, grants from MSD, grants from Allergan, grants from Novartis, grants from Medtronic, grants from GlaxoSmithKline, grants from Novartis, grants from TEVA, grants from Lundbeck, grants from Solvay, grants from BIAL, grants from Merck-Serono, grants from Merz, grants from Ipsen, grants from Biogen, grants from Acadia, grants from Allergan, grants from Abbvie, grants from Sunovion Pharmaceuticals, personal fees from Faculdade de Medicina de Lisboa, personal fees from CNS - Campus Neurol\u00f3gico S\u00e9nior, personal fees from BIAL, personal fees from Novartis, outside the submitted work. S.B. is supported by the National Research Foundation of South Africa (Grant 129249) and the South African Medical Research Council (Self-Initiated Research Grant). E.T. received honoraria for consultancy from TEVA, Bial, Prevail Therapeutics, Boehringer Ingelheim, Roche and BIOGEN and has received funding for research from Spanish Network for Research on Neurodegenerative Disorders (CIBERNED)- Instituto Carlos III (ISCIII), and The Michael J. Fox Foundation for Parkinson\u2019s Research(MJFF). A.P. reports grants from Parkinsonfonden (The Swedish Parkinson Foundation), grants from ALF (Swedish Government), grants from Region Sk\u00e5ne, Sweden, grants from Sk\u00e5ne University Hospital, grants from Hans-Gabriel och Trolle Wachtmeister Stiftelse f\u00f6r Medicinsk Forskning, Sweden, grants from Multipark \u2013 a strategic research environment at Lund University, during the conduct of the study; personal fees from Elsevier, outside the submitted work.M.T. reports grants from Parkinson\u2019s UK, other from Michael J Fox Foundation, other from University College London, outside the submitted work. D.K. is Associate Editor of The Journal of Clinical Investigation. D.K. was not involved in the journal\u2019s review of, or decisions related to, this manuscript. D.K. is also a Venture Partner at OrbiMed, founder and SAB chair at Vanqua BIO, founder of LTI, outside the submitted work. R.K. reports grants from Fonds National de Recherche (FNR), grants from German Research Council (DFG), non-financial support from Abbvie, Zambon, during the conduct of the study; personal fees from University of Luxembourg; Luxembourg Institute of Health; Centre Hospitalier de Luxembourg, grants from Fonds National de Recherche, Luxembourg (FNR), grants from Fonds National de Recherche, Luxembourg (FNR), grants from Fonds National de Recherche (FNR), Luxembourg\/German Research Council (DFG), grants from Fonds National de Recherche, Luxembourg (FNR), personal fees from Desitin\/Zambon, personal fees from Abbvie GmbH, personal fees from Medtronic GmbH, outside the submitted work. T.G. reports personal fees from UCB Pharma, personal fees from Novartis, personal fees from Teva, personal fees from MedUpdate, grants from The Michael J Fox Foundation for Parkinson\u00b4s Research, grants from Bundesministerium f\u00fcr Bildung und Forschung (BMBF), grants from Deutsche Forschungsgemeinschaft (DFG), other from \u201cJoint Programming for Neurodegenerative Diseases\"(JPND) program, funded by the European Commission, outside the submitted work; In addition, T.G. has a patent. Patent Number: EP1802749 (A2) KASPP (LRRK2) gene, its production and use for the detection and treatment of neurodegenerative disorders issued. T.G. is on the Editorial board of Neurogenetics. T.G.r was not involved in the journal\u2019s review of, or decisions related to, this manuscript. A.E. reports grants from Agence nationale de recherche (ANR), Michael J Fox foundation, Plan Ecophyto (French ministry of agriculture), and France Parkinson, outside the submitted work. M.S. reports grants from German Research Council (DFG) (SH 599\/16-1), Michael J Foundation (MJFF), and GP2. N.L.P. reports grants from Swedish Research Council, during the conduct of the study. K.W. reports grants from Swedish Research Council, during the conduct of the study. K.W. was supported by Region Stockholm (clinical research appointment).The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}